The federal government has confirmed that a total of 8,439 cases of mild, adverse effects have occurred over the application of Astrazeneca vaccine in the country.
The National Primary Healthcare Development Agency, (NPHCDA) stated this at a joint press conference with the World Health Organisation (WHO) on Friday in Abuja.
The cases, according to the government came out of over a million persons vaccinated with the AstraZeneca COVID-19 vaccines.
Related Posts
Read also: Sanwo-Olu flags off rail project to commute 1m Lagosians daily in 2022
Executive Director of NPHCDA, Dr. Faisal Shuaib, explained that 52 persons suffered moderate to severe adverse events at inoculation.
Shuaib said some persons had mild reactions like body pains nausea, and swelling, the moderate to severe adverse events presented were fever, vomiting, diarrhea headaches, dizziness and allergic reactions.
He said Kaduna State recorded the highest rate of AEFI with 970 cases, followed by Cross River State with 859 cases, Yobe 541 cases, Kebbi 511 cases while Lagos recorded 448 cases of adverse events.
However, he said that so far, there has been no case of death or blood clot recorded from the AstraZeneca COVID-19 vaccine vaccination in the country, he maintained that the vaccination rollout in the country has been marked by safety, efficiency, best practice, and speed.
